Results 111 to 120 of about 5,449 (190)

Emergence of carbapenemase KPC-14 in an <i>Escherichia coli</i> isolate: a case report. [PDF]

JAC Antimicrob Resist
Fontán García-Rodrigo L, Díez Aguilar M, Sevillano Tripero L, Semiglia Chong MA, Cardeñoso Domingo L.   +4 more
europepmc   +1 more source

<i>In vitro</i> activities of aztreonam/nacubactam and cefepime/nacubactam against a global collection of molecularly characterized Enterobacterales isolates carrying carbapenemases: a global antimicrobial resistance surveillance study from 2021 to 2023. [PDF]

JAC Antimicrob Resist
Estabrook M, Suzuki E, Shimizu A, Okade H.   +3 more
europepmc   +1 more source

Mechanisms involved in cefiderocol resistance in French <i>Pseudomonas aeruginosa</i> clinical strains. [PDF]

Antimicrob Agents Chemother
Gauthier E, Pisani M, Bour M, Grosjean M, Plésiat P, Safari S, Hartkoorn RC, Souro L, Prétot E, Jeannot K.   +9 more
europepmc   +1 more source

Real-World Use of Cefiderocol for Multidrug-Resistant Gram-Negative Infections in Critically Ill ICU Patients: A Single-Center Case Series. [PDF]

Pathogens
Ritiu SA, Baloi A, Păpurică M, Sandesc D, Toma D, Bârsac CR, Popovici SE, Butaș M, Botoaca AM, Bedreag O.   +9 more
europepmc   +1 more source

Cefiderocol Susceptibility in Japanese Clinical Enterobacterales Isolates and the Effect of IMP-Type Carbapenemases on Resistance. [PDF]

Antibiotics (Basel)
Cai M, Yamamoto G, Hamaguchi S, Ueda A, Kawahara R, Motooka D, Takahashi Y, Kutsuna S.   +7 more
europepmc   +1 more source

Comparative evaluation of the activity of novel β-lactam antibiotics against difficult-to-treat <i>Pseudomonas aeruginosa</i> clinical isolates. [PDF]

JAC Antimicrob Resist
Mystakelis H, Shields RK, Mathers AJ, Bergman Y, Munita JM, Cosgrove SE, Simner PJ, Tamma PD.   +7 more
europepmc   +1 more source

Characterization of the intrinsic AmpC β-lactamase of Escherichia marmotae and its impact on decreased susceptibility to cefiderocol and resistance to broad-spectrum cephalosporins. [PDF]

J Antimicrob Chemother
Freire S, Alvarez SM, Findlay J, Vogel M, Nordmann P, Poirel L.   +5 more
europepmc   +1 more source

Effective cefiderocol CSF penetration for treating <i>Stenotrophomonas maltophilia</i> ventriculitis. [PDF]

JAC Antimicrob Resist
Ribera C, Padullés A, Tubau F, Corral L, Nuñez Garate M, Cabellos C, Vilalta A, Càmara J, Cobo-Sacristán S, Abelenda-Alonso G, Di Paolo F, Shaw E, Puig-Asensio M.   +12 more
europepmc   +1 more source

<i>In vitro</i> susceptibility of <i>Stenotrophomonas maltophilia</i> and other carbapenem non-susceptible Gram-negative rods in the Pacific Northwest to cefiderocol and aztreonam-avibactam. [PDF]

JAC Antimicrob Resist
Bryan A, Shields-Pruiett M, Berger H, Fang FC, Penewit K, Waalkes A, Holmes EA, Salipante SJ, Werth BJ.   +8 more
europepmc   +1 more source

Small colony variants and cefiderocol resistance in clinical <i>Escherichia coli</i>: an <i>in vitro</i> mechanistic study. [PDF]

Front Microbiol
Syed MA, Pu D, Song R, Zhao J, Cao B.
europepmc   +1 more source